Ameliorative Effect of

Susu Tao, Yi Qi, Jialong Gao, Huafang Yuan, Ruimin Wang, Xiaoqin Shen, Gang Wei, Zhilan Peng

Abstract read

In one paragraph

Article in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

Sulforaphane attenuates cisplatin‑induced acute kidney injury by inhibiting oxidative stress, inflammation and apoptosis via regulation of NRF2.Molecular medicine reports · 2026
Article
The possible role of astaxanthin in cisplatin-induced nephrotoxicity in rats: interplay between non-coding RNA, redox state, inflammation, and ferroptosis: a histological, immunohistochemical, and biochemical study.Journal of molecular histology · 2026
Article
Pharmaceutics · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Susu TaoSchool of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang 524023, China.

Yi QiSchool of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang 524023, China.

Jialong GaoCollege of Food Science & Technology, Guangdong Provincial Key Laboratory of Aquatic Products Processing and Safety, Zhanjiang 524088, China.

Huafang YuanThe Marine Biomedical Research Institute of Guangdong Zhanjiang, Zhanjiang 524023, China.

Ruimin WangThe Marine Biomedical Research Institute of Guangdong Zhanjiang, Zhanjiang 524023, China.

Xiaoqin ShenThe Marine Biomedical Research Institute of Guangdong Zhanjiang, Zhanjiang 524023, China.

Gang WeiSchool of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang 524023, China.

Zhilan PengSchool of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang 524023, China.

Funding

Guangdong Medical university 4RS23002hGuangdong Provincial Key Laboratory of Aquatic Product Processing and Safety GDPKLAPPS20l7

6 · The paper itself

Abstract

The present study investigated the protective effects and possible mechanisms of an ultrafiltration fraction of

Indexed as

CisplatinKidney DiseasesOxidative StressProtein HydrolysatesAnimalsAntineoplastic AgentsAntioxidantsApoptosisCytokinesInflammationKidneyMaleMiceAntineoplastic AgentsAntioxidantsCisplatinCytokinesProtein Hydrolysatesapoptosiscisplatinhydrolysateinflammationnephrotoxicityoxidative stressSipunculus nudus

Identifiers

PMID40137286

DOI10.3390/md23030100

PMCPMC11943811

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.